Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px
Document › Details

SkinBioTherapeutics plc. (4/5/17). "Press Release: First Day of Dealings. Company to Trade under Ticker Code SBTX [Not for US, AU, CA, JP, ZA, IE, et al.]". Manchester.

Organisations Organisation SkinBioTherapeutics plc (AIM: SBTX)
  Organisation 2 Seneca Partners Ltd.
Products Product microbiomic treatment (live biotherapeutics)
  Product 2 investment banking
Index term Index term SkinBioTherapeutics–SEVERAL: investment, 201703–201704 IPO listing at AIM + placing £4.5m net £4.1m incl cornerstone investor Seneca Partners
Persons Person O’Neill, Catherine (SkinBioTherapeutics plc 201704 CEO)
  Person 2 Toyne-Sewell, Melanie (Instinctif Partners 201509)
     


   
Record changed: 2017-04-12

Advertisement

Picture Lipotype Lipidomics Drug Biomarker Discovery iito 600x60px

More documents for SkinBioTherapeutics plc (AIM: SBTX)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px




» top